Safety and efficacy of high-dose versus low-dose aspirin in individuals with ST elevation myocardial infarction undergoing prima
![Dose- and time-dependent antiplatelet effects of aspirin Christina Perneby, N. Håkan Wallén, Cathy Rooney, Desmond Fitzgerald, Paul Hjemdahl Published. - ppt download Dose- and time-dependent antiplatelet effects of aspirin Christina Perneby, N. Håkan Wallén, Cathy Rooney, Desmond Fitzgerald, Paul Hjemdahl Published. - ppt download](https://images.slideplayer.com/23/6600139/slides/slide_10.jpg)
Dose- and time-dependent antiplatelet effects of aspirin Christina Perneby, N. Håkan Wallén, Cathy Rooney, Desmond Fitzgerald, Paul Hjemdahl Published. - ppt download
![cardio-met on Twitter: "34) So now we turn attention to another area of uncertainty with respect to #aspirin: what is the optimal formulation? If you follow us here at @cardiomet_CE, you should cardio-met on Twitter: "34) So now we turn attention to another area of uncertainty with respect to #aspirin: what is the optimal formulation? If you follow us here at @cardiomet_CE, you should](https://pbs.twimg.com/media/FGC11x2XEA0n5bD.jpg)
cardio-met on Twitter: "34) So now we turn attention to another area of uncertainty with respect to #aspirin: what is the optimal formulation? If you follow us here at @cardiomet_CE, you should
![Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial - The Lancet Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial - The Lancet](https://www.thelancet.com/cms/attachment/2001011700/2003799714/gr1.gif)
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial - The Lancet
![Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan](https://www.frontiersin.org/files/Articles/522921/fped-08-00249-HTML-r1/image_m/fped-08-00249-t001.jpg)
Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan
![Low‐Dose Aspirin for Primary Prevention of Cardiovascular Disease: Use Patterns and Impact Across Race and Ethnicity in the Southern Community Cohort Study | Journal of the American Heart Association Low‐Dose Aspirin for Primary Prevention of Cardiovascular Disease: Use Patterns and Impact Across Race and Ethnicity in the Southern Community Cohort Study | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/de412b64-6ec7-4263-b01b-654d5d0063b9/jah34577-fig-0001.png)
Low‐Dose Aspirin for Primary Prevention of Cardiovascular Disease: Use Patterns and Impact Across Race and Ethnicity in the Southern Community Cohort Study | Journal of the American Heart Association
![Low-Dose Aspirin Is Adequate for Venous Thromboembolism Prevention Following Total Joint Arthroplasty: A Systematic Review - ScienceDirect Low-Dose Aspirin Is Adequate for Venous Thromboembolism Prevention Following Total Joint Arthroplasty: A Systematic Review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S088354031930926X-gr1.jpg)
Low-Dose Aspirin Is Adequate for Venous Thromboembolism Prevention Following Total Joint Arthroplasty: A Systematic Review - ScienceDirect
![Variability in the Responsiveness to Low-Dose Aspirin: Pharmacological and Disease-Related Mechanisms Variability in the Responsiveness to Low-Dose Aspirin: Pharmacological and Disease-Related Mechanisms](https://static-02.hindawi.com/articles/thrombosis/volume-2012/376721/figures/376721.fig.002.jpg)
Variability in the Responsiveness to Low-Dose Aspirin: Pharmacological and Disease-Related Mechanisms
![Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers | SpringerLink Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-021-05562-9/MediaObjects/125_2021_5562_Figa_HTML.png)
Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers | SpringerLink
![Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial - The Lancet Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/65625946-2cd8-4243-ba38-39c85c41ef15/gr1.gif)
Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial - The Lancet
![Aspirin and blood pressure: Effects when used alone or in combination with antihypertensive drugs | Revista Portuguesa de Cardiologia (English edition) Aspirin and blood pressure: Effects when used alone or in combination with antihypertensive drugs | Revista Portuguesa de Cardiologia (English edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S0870255117302895:gr3.jpeg?xkr=ue/ImdikoIMrsJoerZ+w94UphxYc+GPca8Z7OggvdfJQF4SIqTc4zp8SrbcUWBiKS3MUmaOyBgX/+OSVD6Xz3KR4OpfcndY67UrcKw8otPFTgrk4rLrmbisdgOgzzDC9lQOzZmOTyaJLXST5gh3O2nGtBR3tbqE6drak6m70Ioa8JkMK7bBuskK3FEc+hZ4OMJ21RmkExsEnSkrE9ziNEUaM8gRrvWmynPiLvqj6LHecRFN7f1O3L683F9aI6TfP+CV/w09ALW1lL9oFkB9ce4qGkyB1HB2XJBXIjsC6i4o=)